Literature DB >> 19501589

Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis.

Andrea Haegebarth1, Ansu O Perekatt, Wenjun Bie, Jessica J Gierut, Angela L Tyner.   

Abstract

BACKGROUND & AIMS: Protein tyrosine kinase 6 (PTK6) is expressed in epithelial linings of the gastrointestinal tract. PTK6 sensitizes the nontransformed Rat1a fibroblast cell line to apoptotic stimuli. The aim of this study was to determine if PTK6 regulates apoptosis in vivo after DNA damage in the small intestine.
METHODS: Wild-type and Ptk6(-/-) mice were subjected to gamma-irradiation; intestinal tissues were collected, protein was isolated, and samples were fixed for immunohistochemical analyses at 0, 6, and 72 hours after the mice were irradiated. Expression of PTK6 was examined in the small intestine before and after irradiation. Apoptosis and proliferation were compared between wild-type and Ptk6(-/-) mice. Expression and activation of prosurvival signaling proteins were assessed.
RESULTS: Irradiation induced PTK6 in crypt epithelial cells of the small intestine in wild-type mice. Induction of PTK6 corresponded with DNA damage-induced apoptosis in the wild-type small intestine. Following irradiation, the apoptotic response was impaired in the intestinal crypts of Ptk6(-/-) mice. Increased activation of AKT and extracellular signal-regulated kinase (ERK)1/2 and increased inhibitory phosphorylation of the proapoptotic protein BAD were detected in Ptk6(-/-) mice after irradiation. In response to the induction of apoptosis, compensatory proliferation increased in the small intestines of wild-type mice but not in Ptk6(-/-) mice at 6 hours after irradiation.
CONCLUSIONS: PTK6 is a stress-induced kinase that promotes apoptosis by inhibiting prosurvival signaling. After DNA damage, induction of PTK6 is required for efficient apoptosis and inhibition of AKT and ERK1/2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501589      PMCID: PMC2767275          DOI: 10.1053/j.gastro.2009.05.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

1.  Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine.

Authors:  Christopher S Potten
Journal:  Radiat Res       Date:  2004-02       Impact factor: 2.841

2.  Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.

Authors:  X Fang; S Yu; A Eder; M Mao; R C Bast; D Boyd; G B Mills
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

Review 3.  Radiation-induced cell signaling: inside-out and outside-in.

Authors:  Kristoffer Valerie; Adly Yacoub; Michael P Hagan; David T Curiel; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

Review 4.  A comprehensive study of the radiobiological response of the murine (BDF1) small intestine.

Authors:  C S Potten
Journal:  Int J Radiat Biol       Date:  1990-12       Impact factor: 2.694

5.  Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

Authors:  A Bonni; A Brunet; A E West; S R Datta; M A Takasu; M E Greenberg
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

6.  Rsk1 mediates a MEK-MAP kinase cell survival signal.

Authors:  A Shimamura; B A Ballif; S A Richards; J Blenis
Journal:  Curr Biol       Date:  2000-02-10       Impact factor: 10.834

7.  Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.

Authors:  B J Petro; R C Tan; A L Tyner; M W Lingen; K Watanabe
Journal:  Oral Oncol       Date:  2004-11       Impact factor: 5.337

8.  Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.

Authors:  Jason J Derry; Gail S Prins; Vera Ray; Angela L Tyner
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

Review 9.  Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.

Authors:  Michael S Serfas; Angela L Tyner
Journal:  Oncol Res       Date:  2003       Impact factor: 5.574

10.  Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon.

Authors:  Aleksandra Jovanovic Poole; Darien Heap; Robert E Carroll; Angela L Tyner
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

View more
  29 in total

Review 1.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

2.  Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

Authors:  Jessica Gierut; Yu Zheng; Wenjun Bie; Robert E Carroll; Susan Ball-Kell; Andrea Haegebarth; Angela L Tyner
Journal:  Gastroenterology       Date:  2011-07-08       Impact factor: 22.682

3.  Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.

Authors:  Priya S Mathur; Jessica J Gierut; Grace Guzman; Hui Xie; Rosa M Xicola; Xavier Llor; Michael I Chastkofsky; Ansu O Perekatt; Angela L Tyner
Journal:  Mol Cancer Res       Date:  2016-03-16       Impact factor: 5.852

Review 4.  Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy.

Authors:  Haroon A Hussain; Amanda J Harvey
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.

Authors:  Helena L Palka-Hamblin; Jessica J Gierut; Wenjun Bie; Patrick M Brauer; Yu Zheng; John M Asara; Angela L Tyner
Journal:  J Cell Sci       Date:  2009-12-21       Impact factor: 5.285

Review 6.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

7.  PTK6 regulates IGF-1-induced anchorage-independent survival.

Authors:  Hanna Y Irie; Yashaswi Shrestha; Laura M Selfors; Fabianne Frye; Naoko Iida; Zhigang Wang; Lihua Zou; Jun Yao; Yiling Lu; Charles B Epstein; Sridaran Natesan; Andrea L Richardson; Kornelia Polyak; Gordon B Mills; William C Hahn; Joan S Brugge
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

8.  Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.

Authors:  Nancy E Castro; Carol A Lange
Journal:  Breast Cancer Res       Date:  2010-08-05       Impact factor: 6.466

9.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

10.  Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.

Authors:  Jessica J Gierut; Priya S Mathur; Wenjun Bie; Jin Han; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2012-09-18       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.